Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 6/2018

01-06-2018 | Invited Article

Esophagography and gastroesophageal reflux disease: utilization and utility

Author: David J. DiSantis

Published in: Abdominal Radiology | Issue 6/2018

Login to get access

Excerpt

The fluoroscopic study of the esophagus has come a long, long way since medical student Walter B. Cannon watched a dog swallow pearl buttons in December of 1896 [1]. For much of the twentieth century, a “barium swallow” was the way that medicine examined the esophagus. The advent of endoscopy, manometry, and esophageal pH monitoring rightfully prompts reassessment of fluoroscopy’s proper role in the evaluation of esophageal disease, including gastroesophageal reflux disease. Is the esophagram still relevant? …
Literature
1.
Cannon WB (1913) Early use of the roentgen ray in the study of the alimentary canal. In: Reprints from the Writings of W.B. Cannon (digitized version). Bibliolife DBA Bazaar II LLC. ISBN 1345937288, 9781345937282. Google books ID: uNdwAAAAIAAJ. Accessed 31 October 2017
2.
3.
4.
5.
6.
7.
8.
Okamoto K, Iwakiri R, Mori M, et al. (2003) Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci 48:2237–2241 (PMID: 14714607)CrossRefPubMed
9.
Vakil NB, Traxler B, Levine D (2004) Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment. Clin Gastroenterol Hepatol. 2:665–668CrossRefPubMed
10.
Jacob P, Kahrilas PJ, Vanagunas A (1990) Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease. Dig Dis Sci 35:939–942CrossRefPubMed
11.
Metadata
Title
Esophagography and gastroesophageal reflux disease: utilization and utility
Author
David J. DiSantis
Publication date
01-06-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1470-y

Other articles of this Issue 6/2018

Abdominal Radiology 6/2018 Go to the issue

OriginalPaper

Contrast-enhanced ultrasonography for assessment of tubular atrophy/interstitial fibrosis in immunoglobulin A nephropathy: a preliminary clinical study

OriginalPaper

Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft

Pictorial essay

What the radiologist needs to know about gastrointestinal endoscopic surgical procedures

Classics in Abdominal Imaging

Lead pipe sign in ulcerative colitis

OriginalPaper

Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists’ confidence in hepatic lesion assessment on restaging MRIs

Classics in Abdominal Imaging

Thread like calcifications in mesenteric phlebosclerosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits